Latest News

Verdiperstat Fails to Improve ALS Disease Progression, HEALEY-ALS Results Show
Verdiperstat Fails to Improve ALS Disease Progression, HEALEY-ALS Results Show

May 15th 2025

Verdiperstat showed no significant impact on ALS progression in a recent trial, highlighting the challenges of developing effective treatments for this disease.

Frontotemporal Dementia Insights From Baptist Health’s Brain and Spine Symposium
Frontotemporal Dementia Insights From Baptist Health’s Brain and Spine Symposium

May 15th 2025

Overviewing 2025 Baptist Health Brain and Spine Symposium: Exploring New Options in Chronic Pain Management
Overviewing 2025 Baptist Health Brain and Spine Symposium: Exploring New Options in Chronic Pain Management

May 15th 2025

Jannis Müller, MD, MSc  (Credit: LinkedIn)
Observed Differences in PIRA Definition Call for More Standardized Agreement on Term

May 14th 2025

Newborn Screening, Enzyme Delivery, and the Future of Pompe Disease Treatment
Newborn Screening, Enzyme Delivery, and the Future of Pompe Disease Treatment

May 14th 2025

Coverage of the 2025 AAN Annual Meeting

Get direct access to interviews with experts, as well as the latest data and clinical news updates, straight from the conference floor in San Diego.

AAN 2025

Conference Coverage

View All
Bruce Bebo, PhD
Recognizing Scientific Excellence and Impact in Multiple Sclerosis Research: Bruce Bebo, PhD

May 15th 2025

Jack P. Antel, M D
Advancing MS Care Through Early Intervention and Deeper CNS Insights: Jack P. Antel, MD

May 15th 2025

Newborn Screening, Enzyme Delivery, and the Future of Pompe Disease Treatment
Newborn Screening, Enzyme Delivery, and the Future of Pompe Disease Treatment

May 14th 2025

Insights on Quanterix Simoa Assay to Diagnose Alzheimer Disease: Mark Roskey, PhD
Insights on Quanterix Simoa Assay to Diagnose Alzheimer Disease: Mark Roskey, PhD

May 13th 2025

Video Series
Video Interviews
Podcasts

Most Recent

© 2025 MJH Life Sciences

All rights reserved.